Part of the Pemphigus & Bullous Disorders Knowledge Library
From Marks to Meaning: Interpreting Skin Lesions in Chronic Disorders
Skin lesions, especially those arising in chronic conditions, can be more than just physical marks. In Ayurveda, each lesion and change in skin appearance is viewed as an indicator of underlying doshic imbalances and systemic issues within the body (Lad, 2002). From eczema to psoriasis, Hidradenitis Suppurativa, and Bullous Pemphigoid, chronic skin disorders reflect deeper disharmony in the body’s internal environment (Pole, 2013). Understanding the meaning behind these lesions can offer insights into root causes, paving the way for holistic healing. At EliteAyurveda, we employ a comprehensive approach to interpreting and managing skin lesions through the wisdom of Ayurveda, using personalized care to restore balance and improve quality of life (Sharma & Chandola, 2011).
Interpreting Skin Lesions in Chronic Disorders
Ayurveda views the skin as a mirror of the body’s internal state, reflecting the balance (or imbalance) of the three doshas—Vata, Pitta, and Kapha—as well as the body’s ability to eliminate toxins (Ama) (Frawley, 2000). Skin lesions, therefore, provide valuable clues about underlying physiological imbalances, immune responses, and even emotional states (Mishra, 2004). For individuals with chronic skin conditions, these signs help guide a personalized treatment plan that addresses not only surface symptoms but also the root imbalances (Pole, 2013).
Understanding these signs enables Ayurvedic practitioners at EliteAyurveda to create a treatment plan that targets the root causes of these skin lesions, aiming to restore doshic harmony and improve overall health (Sharma & Chandola, 2011).
Skin lesions in chronic disorders manifest in various ways, each pointing to different underlying issues. Here are some common types and their Ayurvedic interpretations:
Red, inflamed lesions are typically seen in conditions like eczema and Bullous Pemphigoid, often accompanied by heat, itching, and discomfort (Kasture et al., 2013). These lesions are indicative of excessive Pitta, the dosha associated with heat, digestion, and transformation. When Pitta is imbalanced, it creates inflammation and sensitivity, leading to the red, inflamed marks characteristic of Pitta-dominant conditions (Frawley, 2000).
Blisters, abscesses, and fluid-filled lesions are commonly seen in conditions like Hidradenitis Suppurativa and certain types of dermatitis (Schmidt & Zillikens, 2013). These lesions are signs of Kapha dominance, reflecting congestion, blocked pores, and fluid retention (Dass, 2013). Kapha’s heavy, moist qualities create a favorable environment for abscess formation, slow healing, and chronic congestion in the skin (Pole, 2013).
Dry, cracked, or flaky lesions often appear in chronic conditions like psoriasis and certain types of eczema (Venning, 2003). These lesions are associated with Vata imbalances, which bring dryness, roughness, and instability to the skin (Dass, 2013). Vata’s cold and dry nature exacerbates skin dehydration, leading to discomfort, flaking, and poor resilience in affected areas (Lad, 2002).
At EliteAyurveda, we go beyond surface-level treatments by addressing the internal imbalances that give rise to skin lesions (Sharma & Chandola, 2011). Our approach includes a combination of dietary guidance, personalized herbal medications, lifestyle adjustments, and mind-body practices that help restore balance and improve skin health (Pole, 2013).
In Ayurveda, diet plays a significant role in managing doshic imbalances that manifest as skin lesions (Lad, 2002). Each dosha has specific dietary needs, and choosing foods accordingly supports the body’s natural healing.
EliteAyurveda’s herbal formulations are customized for each patient, targeting specific doshic imbalances and supporting skin regeneration without side effects (Sharma & Chandola, 2011).
A consistent daily routine, or Dinacharya, stabilizes doshas, supports immune health, and helps the body establish a natural rhythm, which is essential for managing chronic skin conditions (Lad, 2002).
Chronic skin conditions can be both physically and emotionally challenging. Ayurveda places great emphasis on emotional balance as part of a comprehensive healing plan (Kasture et al., 2013).
Ayurveda recognizes that each season affects doshic balance differently, impacting chronic skin disorders (Lad, 2002). Adapting to these seasonal changes helps prevent doshic aggravation and maintains skin health.
Ayurvedic management provides sustainable relief by addressing the root causes of skin lesions, supporting internal balance, and promoting skin resilience (Sharma & Chandola, 2011). Key long-term benefits include:
At EliteAyurveda, we offer personalized care that goes beyond treating symptoms to address the root causes of chronic skin conditions (Sharma & Chandola, 2011). Our experienced practitioners develop individualized plans with Ayurvedic herbs, dietary guidance, lifestyle adjustments, and emotional support, helping patients achieve natural, sustainable relief and improved quality of life (Pole, 2013).
If you’re looking for a holistic, patient-centered approach to managing chronic skin lesions, EliteAyurveda offers the expertise, care, and personalized support you need to navigate your healing journey naturally (EliteAyurveda, n.d.).
Related-
Know More About Ayurveda Treatments for Dermatology.
GET IN TOUCH
Contact us
References
1.Badia M., Casanova J.M., Serviá L., Montserrat N., Codina J., Trujillano J. Dermatological Manifestations in the Intensive Care Unit: A Practical Approach. Crit. Care Res. Pract. 2020;2020:9729814. doi: 10.1155/2020/9729814. [DOI] [PMC free article] [PubMed] [Google Scholar]
2.Srivastava A., Mathur A.D., Agarwal S. Dermatological Disorders in the Intensive Care Unit: A Descriptive Study at a Tertiary Care Centre. J. Assoc. Phys. India. 2021;11:11–12. [PubMed] [Google Scholar]
3.Bromley M., Marsh S., Layton A. Dermatological complications of critical care. BJA Educ. 2021;21:408–413. doi: 10.1016/j.bjae.2021.05.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
4.Copaescu A.M., Trubiano J.A. The assessment of severe cutaneous adverse drug reactions. Aust. Prescr. 2022;45:43–48. doi: 10.18773/austprescr.2022.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
5.Lee A. Skin manifestations of systemic disease. Aust. Fam. Phys. 2009;38:498–505. [PubMed] [Google Scholar]
6.Bajwa S.J., Singh K.P., Kaur N. Dermatologic manifestations in critically ill patients: Challenging task for an intensivist. J. Med. Soc. 2013;27:3–9. doi: 10.4103/0972-4958.116620. [DOI] [Google Scholar]
7.Ellis J., Harvey D., Defres S., Chandna A., MacLachlan E., Solomon T., Heyderman R.S., McGill F. Clinical management of community-acquired meningitis in adults in the UK and Ireland in 2017: A retrospective cohort study on behalf of the National Infection Trainees Collaborative for Audit and Research (NITCAR) BMJ Open. 2022;12:e062698. doi: 10.1136/bmjopen-2022-062698. [DOI] [PMC free article] [PubMed] [Google Scholar]
8.Gkoufa A., Sklapani P., Trakas N., Georgakopoulou V.E. A Challenging Cutaneous Lesion in a Patient With Chronic Idiopathic Neutropenia. Cureus. 2022;14:e21225. doi: 10.7759/cureus.21225. [DOI] [PMC free article] [PubMed] [Google Scholar]
9.Martínez-Longoria C.A., Rosales-Solis G.M., Ocampo-Garza J., Guerrero-González G.A., Ocampo-Candiani J. Ecthyma gangrenosum: A report of eight cases. An. Bras. Dermatol. 2017;92:698–700. doi: 10.1590/abd1806-4841.20175580. [DOI] [PMC free article] [PubMed] [Google Scholar]
10.Awal G., Kaur T. Dermatological manifestations in the ICU: A prospective observational analysis. J. Egypt. Women’s Dermatol. Soc. 2018;15:94–99. doi: 10.1097/01.EWX.0000531118.39262.73. [DOI] [Google Scholar]
11.Metkus T.S., Kim B.S. Bedside Diagnosis in the Intensive Care Unit. Is Looking Overlooked? Ann. Am. Thorac. Soc. 2015;12:1447–1450. doi: 10.1513/AnnalsATS.201505-271OI. [DOI] [PMC free article] [PubMed] [Google Scholar]
12.Jack A.R., Spence A.A., Nichols B.J., Peng D.H. A simple algorithm for evaluating dermatologic disease in critically ill patients: A study based on retrospective review of medical intensive care unit consults. J. Am. Acad. Dermatol. 2009;61:728–730. doi: 10.1016/j.jaad.2008.12.025. [DOI] [PubMed] [Google Scholar]
13.Dunnill M.G., Handfield-Jones S.E., Treacher D., McGibbon D.H. Dermatology in the intensive care unit. Br. J. Dermatol. 1995;132:226–235. doi: 10.1111/j.1365-2133.1995.tb05018.x. [DOI] [PubMed] [Google Scholar]
14.Porro A.M., Seque C.A., Ferreira M.C.C., Enokihara M.M.S.E.S. Pemphigus vulgaris. An. Bras. Dermatol. 2019;94:264–278. doi: 10.1590/abd1806-4841.20199011. [DOI] [PMC free article] [PubMed] [Google Scholar]
15.Hutchison D.M., Hosking A.M., Hong E.M., Grando S.A. Mitochondrial Autoantibodies and the Role of Apoptosis in Pemphigus Vulgaris. Antibodies. 2022;11:55. doi: 10.3390/antib11030055. [DOI] [PMC free article] [PubMed] [Google Scholar]
16.Kasperkiewicz M., Zillikens D. The Pathophysiology of Bullous Pemphigoid. Clin. Rev. Allergy Immunol. 2007;33:67–77. doi: 10.1007/s12016-007-0030-y. [DOI] [PubMed] [Google Scholar]
17.Pile H.D., Yarrarapu S.N.S., Crane J.S. StatPearls [Internet] StatPearls Publishing; Treasure Island, FL, USA: 2022. [(accessed on 5 February 2023)]. Drug Induced Pemphigus. Available online: https://www.ncbi.nlm.nih.gov/books/NBK499864/ [PubMed] [Google Scholar]
18.De Simone C., Caldarola G., D’agostino M., Zampetti A., Amerio P., Feliciani C. Exacerbation of pemphigus after influenza vaccination. Clin. Exp. Dermatol. 2008;33:718–720. doi: 10.1111/j.1365-2230.2008.02835.x. [DOI] [PubMed] [Google Scholar]
19.Bice K., Hood C., Almukhtar R., Gerdes M., Martin P., Lee B. Pemphigus Vulgaris Following Influenza: A Case Report. SKIN J. Cutan. Med. 2019;3:418–422. doi: 10.25251/skin.3.6.9. [DOI] [Google Scholar]
20.Sinha P., Chatterjee M., Vasudevan B. Pemphigus vulgaris: A dermatological sequel of severe H1N1 infection. Indian Derm. Online J. 2014;5:216–217. doi: 10.4103/2229-5178.131131. [DOI] [PMC free article] [PubMed] [Google Scholar]
21.Korang K., Ghohestani R., Krieg T., Uitto J., Hunzelmann N. Exacerbation of pemphigus foliaceus after tetanus vaccination accompanied by synthesis of auto-antibodies against paraneoplastic pemphigus antigens. Acta Derm.-Venereol. 2002;82:482–483. doi: 10.1080/000155502762064755. [DOI] [PubMed] [Google Scholar]
22.Solimani F., Mansour Y., Didona D., Dilling A., Ghoreschi K., Meier K. Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2. J. Eur. Acad. Dermatol. Venereol. 2021;35:e649–e651. doi: 10.1111/jdv.17480. [DOI] [PMC free article] [PubMed] [Google Scholar]
23.Martora F., Fabbrocini G., Nappa P., Megna M. Reply to ‘Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2’ by Solimani et al. J. Eur. Acad. Dermatol. Venereol. 2022;36:e750–e751. doi: 10.1111/jdv.18302. [DOI] [PMC free article] [PubMed] [Google Scholar]
24.Corrá A., Barei F., Genovese G., Zussino M., Spigariolo C.B., Mariotti E.B., Quintarelli L., Verdelli A., Caproni M., Marzano A.V. Five cases of new-onset pemphigus following vaccinations against coronavirus disease 2019. J. Dermatol. 2023;50:229–233. doi: 10.1111/1346-8138.16554. [DOI] [PMC free article] [PubMed] [Google Scholar]
Medical disclaimer. This article is for general information and is not a substitute for personalised medical advice. Ayurvedic treatment at EliteAyurveda is individualised following clinical assessment. Do not start, stop or alter any prescribed medication without consulting your treating physician.